Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Anagrelide hydrochloride (BL4162A) serves as a treatment for essential thrombocytosis.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
5 mg | 在庫あり | ¥ 8,000 | |||
10 mg | 在庫あり | ¥ 11,500 | |||
25 mg | 在庫あり | ¥ 18,500 | |||
50 mg | 在庫あり | ¥ 37,000 | |||
100 mg | 在庫あり | ¥ 67,000 | |||
200 mg | 在庫あり | ¥ 105,000 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 11,500 |
説明 | Anagrelide hydrochloride (BL4162A) serves as a treatment for essential thrombocytosis. |
In vitro | Anagrelide is an oral imidazoquinazoline agent with an anti-cyclic AMP phosphodiesterase activity and inhibits platelet aggregation in both humans and animals. Anagrelide works by inhibiting the maturation of platelets from megakaryocytes. |
別名 | BMY 26538-01, Anagrelide HCl, Agrylin, BL4162A |
分子量 | 292.55 |
分子式 | C10H7Cl2N3O·HCl |
CAS No. | 58579-51-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 2.9 mg/mL (10 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Anagrelide hydrochloride 58579-51-4 Metabolism PDE Phosphodiesterase (PDE) Anagrelide inhibit Inhibitor BMY 26538-01 Anagrelide HCl Agrylin Anagrelide Hydrochloride BL4162A inhibitor